All filters
Abstracts
Creation of an Italian HIV DNA Network for the validation and clinical use of HIV-1 DNA quantification assays
I. Vicenti Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Exploratory evaluation for the optimization of next generation sequencing HIV-1 drug resistance outcomes based on an in-house RNA extraction protocol
A. Orta-Resendiz  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Associations between vitamin D and fibrosis, genotype, viral load in patients having chronic hepatitis C
M. Nikolaichuk Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Overview of the national hepatitis B viral load testing programe in Uganda
V. Kasone Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Comparison of the new Alinity m system with the established Abbott RealTime and Hologic Aptima Quant Assay in HIV-1, HCV and HBV viral load measurement including performance and turn-around times
M. Obermeier Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
The Significance of M2BPGi Marker and CCC DNA in Unknown Etiology Hepatitis
E. Kazakova Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
A pan-genotypic nearly whole genome amplification approach of HCV by a simple two-step RT-PCR combined with parallel Oxford Nanopore and Illumina sequencing produce highly accurate long-range sequences
M. Däumer Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
A hybrid sequencing approach for accurate minority detection and resolving haplotype information
A. Thielen Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
The quantification of HBeAg levels differ among the different phases of HBV infection, and can predict therapeutic outcome in the setting of immunosuppression driven HBV reactivation.
L. Piermatteo Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
The effectiveness of the application of serological tests and laboratory indicators as part of RITA for the detection of recent HIV infection
A. Murzakova Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates
C. Charpentier Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
TDR surveillance and clinically relevant resistance in Spain: 2019 update
F. García  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Prevalence of drug resistance mutations to rilpivirine and doravirine among NNRTI-experienced patients in Italy
A. Lai Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HCV resistance associated variants following directly acting agent therapy failure- real life data from Poland
M. Parczewski Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Absence of GS-6207 Phenotypic Resistance in HIV Gag Cleavage Site Mutants, Patient Isolates With Gag Polymorphisms, and Isolates With Resistance To Existing Drug Classes
C. Callebaut Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Prevalence of transmitted resistance mutations to rilpivirine and doravirine in treatment-naive patients in a large clinical and resistance database
F. Lombardi  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Genotyping and treatment issues with unusual 1e and 1g HCV subtypes from African subjects: report of two cases.
C. Caudai Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Susceptibility to bNAbs of transmitted HIV variants among recent infections in France
K. Stefic  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Baseline Hepatitis C Virus NS5A Resistance-Associated Polymorphisms in Patients with and without HIV coinfection in Mexico
B. Lopez Luis Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Substantial clustered transmission of the acute hepatitis C among HIV co-infected men-who-have-sex-with-men (MSM)
D. Van De Vijver Reviews in Antiviral Therapy & Infectious Diseases 7, 2020  
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates
Q. Le Hingrat  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Antiretroviral resistance in patients with multiple treatment failure in a low-middle income setting
J. Castillo-Álvarez  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Late presentation and HIV drug resistance in patients followed in Portugal between 1984-2017
M. Pingarilho Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020